Table 4.
Progression-free survival |
Cause-specific survival |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Survival |
Univariable |
Multivariable |
Survival |
Univariable |
Multivariable |
||||||
Characteristic | No | 2-yr (%) | HR (95%CI) | P-value | HR (95%CI) | P-value | 2-yr (%) | HR (95%CI) | P-value | HR (95%CI) | P-value |
Lymph node metastasis | <0.001 | <0.001 | |||||||||
No | 122 | 79.6 | 1 | 1 | 86.2 | 1 | 1 | ||||
Yes | 9 | 0 | 20.0 (7.83–51.1) | 4.72 (0.92–24.2) | 0.06 | 0 | 27.0 (10.0–72.7) | 6.24 (1.17–33.4) | 0.03 | ||
Sarcomatous overgrowth | <0.001 | <0.001 | |||||||||
No | 68 | 79.4 | 1 | 1 | 92.9 | 1 | 1 | ||||
Yes | 92 | 46.8 | 3.39 (2.07–5.55) | 2.88 (0.99–8.40) | 0.053 | 63.2 | 5.95 (2.93–12.1) | 3.02 (0.70–13.1) | 0.14 | ||
Heterologous elements | <0.001 | <0.001 | |||||||||
No | 119 | 90.2 | 1 | 1 | 96.1 | 1 | 1 | ||||
Yes | 35 | 36.8 | 4.95 (2.74–8.92) | 2.08 (0.70–6.12) | 0.19 | 42.0 | 7.88 (3.97–15.6) | 3.63 (0.90–14.6) | 0.07 | ||
Myometrial invasion | <0.001 | <0.001 | |||||||||
≤50% | 139 | 82.4 | 1 | 1 | 87.2 | 1 | 1 | ||||
>50% | 21 | 36.1 | 3.07 (1.60–5.88) | 1.51 (0.48–4.72) | 0.48 | 50.5 | 4.27 (2.08–8.76) | 1.62 (0.47–5.58) | 0.44 |
A Cox proportional hazard regression model for multivariable analysis adjusted for collected covariates. Significant P-values are emboldened. Abbreviations: 2-yr, 2-year proportion.